What is the current price for "Will the FDA approve retatrutide?"?

The leading outcome "Yes" is currently trading at 95.5% probability.

How many markets are available for "Will the FDA approve retatrutide?"?

There are 5 markets available for this event on Kalshi.

What is the trading volume for "Will the FDA approve retatrutide?"?

Trading volume data is not currently available.

BackKKALSHI

Will the FDA approve retatrutide?

Yes96%

Vol$0.00

Markets5

96%

TradeTrade on Kalshi

Event Group

EventKALSHI

Single EventKALSHIScience and Technology

Will the FDA approve retatrutide?

Name: Will the FDA approve retatrutide?
Start: 2026-07-10T04:48:06.638Z
End: 2026-08-09T04:48:06.638Z

Part of: Will the FDA approve retatrutide?

retatrutide (LY3437943) If the FDA approves retatrutide, LY3437943, for marketing before X 1, Y then the market resolves to Yes. An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application, NDA, or Biologics License Application, BLA, For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA, sNDA, or supplemental BLA, sBLA, for the specific indication referenced For generic drugs: FDA approval of an Abbreviated New Drug Ap

YesLeading Yes Probability

96%

VolTotal Volume

$0.00

Markets

Trade on Kalshi

Will the FDA approve retatrutide?

Yes

96%

Vol

$0.00

Markets

Trade

Market Price Graph

5 markets tracked

When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2029)

kalshi

No data available

All Markets(5)

Market	Price
When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2029)	96%
When will the FDA approve retatrutide (LY3437943)? (Before Jul 1, 2028)	92%
When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2028)	88%
When will the FDA approve retatrutide (LY3437943)? (Before Jul 1, 2027)	73%
When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2027)	13%

Markets (5)

Sort

KALSHIHealth

When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2029)

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2029, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed d

When will the FDA approve retatrutide (LY3437943)? (Before Jul 1, 2028)

If the FDA approves retatrutide (LY3437943) for marketing before Jul 1, 2028, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed d

When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2028)

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2028, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed d

When will the FDA approve retatrutide (LY3437943)? (Before Jul 1, 2027)

If the FDA approves retatrutide (LY3437943) for marketing before Jul 1, 2027, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed d

When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2027)

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2027, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed d